JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.21B |
| 2 |
Microsoft
MSFT
|
+$2.18B |
| 3 |
Tesla
TSLA
|
+$1.1B |
| 4 |
NXP Semiconductors
NXPI
|
+$1.04B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$998M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.32B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 4 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.31B |
| 5 |
PayPal
PYPL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.77% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.83% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Future Fuel
FF
$245M
| $3.21M | ﹤0.01% |
419,597
+27,684
| +7% | +$215K |
|
|
EBIX
3302
DELISTED
Ebix Inc
EBIX
| $3.2M | ﹤0.01% |
105,413
+1,006
| +1% | +$32.1K |
|
3303
Health Catalyst
HCAT
$139M
| $3.2M | ﹤0.01% |
80,812
+39,919
| +98% | +$1.82M |
|
3304
Towne Bank
TOWN
$3.5B
| $3.2M | ﹤0.01% |
101,271
+31,708
| +46% | +$1.01M |
|
3305
Enova International
ENVA
$6.61B
| $3.18M | ﹤0.01% |
77,676
-19
| -0% | -$721 |
|
3306
Fidelity MSCI Health Care Index ETF
FHLC
$3.4B
| $3.17M | ﹤0.01% |
46,204
-75
| -0.2% | -$4.93K |
|
3307
iShares US Healthcare ETF
IYH
$3.75B
| $3.17M | ﹤0.01% |
52,775
-1,230
| -2% | -$70.3K |
|
3308
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $3.17M | ﹤0.01% |
25,932
-81,655
| -76% | -$9.4M |
|
|
TUYA
3309
Tuya Inc
TUYA
$1.12B
| $3.17M | ﹤0.01% |
506,820
-453,771
| -47% | -$3.08M |
|
3310
Kodiak Sciences
KOD
$2.59B
| $3.17M | ﹤0.01% |
37,359
+2,168
| +6% | +$221K |
|
3311
Invesco S&P 500 Low Volatility ETF
SPLV
$7.23B
| $3.16M | ﹤0.01% |
46,082
+35,761
| +346% | +$2.3M |
|
3312
Invesco DB Agriculture Fund
DBA
$1.24B
| $3.15M | ﹤0.01% |
159,642
+64,620
| +68% | +$1.26M |
|
3313
Quanterix
QTRX
$122M
| $3.15M | ﹤0.01% |
74,322
-1,270
| -2% | -$59.3K |
|
3314
OR Royalties Inc
OR
$6.25B
| $3.15M | ﹤0.01% |
+257,029
| New | +$3.13M |
|
|
ZGNX
3315
DELISTED
Zogenix, Inc.
ZGNX
| $3.15M | ﹤0.01% |
193,712
-10,782
| -5% | -$158K |
|
3316
SiriusXM
SIRI
$9.59B
| $3.15M | ﹤0.01% |
49,574
+11,853
| +31% | +$741K |
|
3317
Lineage Cell Therapeutics
LCTX
$271M
| $3.15M | ﹤0.01% |
1,283,277
-932,515
| -42% | -$2.18M |
|
3318
Ooma
OOMA
$572M
| $3.15M | ﹤0.01% |
153,912
+15,089
| +11% | +$307K |
|
3319
Republic Bancorp
RBCAA
$1.92B
| $3.14M | ﹤0.01% |
61,725
+50,098
| +431% | +$2.67M |
|
3320
PUT
MetLife
MET
$62.1B
| $3.14M | ﹤0.01% |
50,200
| – | – |
|
3321
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$926M
| $3.13M | ﹤0.01% |
227,289
| – | – |
|
3322
CALL
Aurinia Pharmaceuticals
AUPH
$2.06B
| $3.13M | ﹤0.01% |
+136,900
| New | +$3.24M |
|
|
PVBC
3323
DELISTED
Provident Bancorp
PVBC
| $3.13M | ﹤0.01% |
168,347
-16,273
| -9% | -$293K |
|
3324
Rallybio
RLYB
$90.2M
| $3.13M | ﹤0.01% |
41,027
+34,151
| +497% | +$3.97M |
|
3325
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.1B
| $3.13M | ﹤0.01% |
40,602
-57,630
| -59% | -$4.7M |
|
Similar funds
JP Morgan Chase's Q4 2021 Portfolio in Review
As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
- JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
- JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
- JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
- JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
- JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
- JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.
Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.